FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/03/050202 [Registered on: 01/03/2023] Trial Registered Prospectively
Last Modified On: 02/03/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Homoeopathic treatment of neck pain 
Scientific Title of Study   Repertorial approach of pain management in cervical radiculopathy in adults by using individualized homoeopathic medicines: Double-blind, randomized, placebo-controlled trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
U1111-1288-7475  UTN 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Swarup Biswas 
Designation  Postgraduate Trainee 
Affiliation  D N De Homoeopathic Medical College and Hospital 
Address  Dept. of Repertory, 12, Gobinda Khatick Road, Tangra

Kolkata
WEST BENGAL
700046
India 
Phone  6290295699  
Fax    
Email  biswasswarup786@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Rajat Kumar Pal 
Designation  Professor and Head 
Affiliation  D N De Homoeopathic Medical College and Hospital 
Address  Dept. of Repertory, 12, Gobinda Khatick Road, Tangra

Kolkata
WEST BENGAL
700046
India 
Phone  9433130996  
Fax    
Email  drrajatkumarpal@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Rajat Kumar Pal 
Designation  Professor and Head 
Affiliation  D N De Homoeopathic Medical College and Hospital 
Address  Dept. of Repertory, 12, Gobinda Khatick Road, Tangra

Kolkata
WEST BENGAL
700046
India 
Phone  9433130996  
Fax    
Email  drrajatkumarpal@gmail.com  
 
Source of Monetary or Material Support  
D N De Homoeopathic Medical College and Hospital, 12, Gobinda Khatick Road, Tangra, Kolkata 700046 
 
Primary Sponsor  
Name  D N De Homoeopathic Medical College and Hospital 
Address  12, Gobinda Khatick Road, Tangra, Kolkata 700046, West Bengal 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
Nil  NA 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Swarup Biswas  D N De Homoeopathic Medical College and Hospital  OPD no. PG3, Research and Medicine, Dept. of Repertory, 12, Gobinda Khatick Road, Tangra Kolkata WEST BENGAL
Kolkata
WEST BENGAL 
6290295699

biswasswarup786@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M541||Radiculopathy,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Identical-looking placebos plus concomitant care  This group will receive placebos, identical in appearance with the verum. Each dose will consist of 4 cane sugar globules no. 40, moistened with 90% v/v ethanol, to be taken orally on clean tongue with empty stomach; dosage and repetition will be decided depending upon the individual requirement of the cases. All sundry items will be procured from a Good Manufacturing Practice (GMP) certified firm. All the enrolled participants will receive advice on concomitant care, i.e., ice cube massage over the painful part of neck, or fomentations, isometric neck exercises, Alexander technique, upper trap stretch, levator scapulae stretch, deep anterior neck flexor stretch, suboccipital stretch, rhomboid and middle trap stretch, use of neck braces, avoiding excess bending of neck and lifting heavy weight on head, neck or shoulder, etc. Duration of therapy: 2 months 
Intervention  Individualized homeopathic medicines in centesimal potencies plus concomitant care  Intervention is planned as administering the indicated homeopathic medicines in centesimal potencies (CH). Each dose will consist of 4 cane sugar globules no. 40 moistened with the indicated medicine (preserved in 90% v/v ethanol), to be taken orally on clean tongue with empty stomach; dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within 30 minutes of taking the globules and will be asked to suck the globules rather than simply swallowing those. All the medicines and sundry items will be procured from a Good Manufacturing Practice (GMP) certified firm. All the enrolled participants will receive advice on concomitant care, i.e., ice cube massage over the painful part of neck, or fomentations, isometric neck exercises, Alexander technique, upper trap stretch, levator scapulae stretch, deep anterior neck flexor stretch, suboccipital stretch, rhomboid and middle trap stretch, use of neck braces, avoiding excess bending of neck and lifting heavy weight on head, neck or shoulder, etc. Duration of therapy: 2 months. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Patients suffering from cervical radiculopathy (ICD10 CM code M54.12) for 3 months or more who shows Spurling’s test positive and Bakody’s sign or positive shoulder abduction test.
2. Age between 18 and 65 years
3. Participants of either sex or transgender
4. Literate participants, ability to read and write in English, Bengali and/or Hindi. Illiterate participants will be interviewed by the investigators maintaining adequate privacy to fill up the scales or questionnaires.
5. Providing with written informed consent voluntarily 
 
ExclusionCriteria 
Details  1. Cases with complications such as incomplete neurological recoveries, disc prolapse, disc herniation.
2. Patients with the history of taking spinal steroid injection within 6 months.
3. Patients on regular NSAIDS therapy.
4. Patients with uncontrolled diabetes mellitus, uncontrolled hypertension, or uncontrolled cardiovascular disease.
5. Vulnerable population - unconscious, non-ambulatory, too sick for consultation, differently abled, terminally ill or critically ill patients, institutionalized subjects, mentally incompetent people.
6. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure.
7. Pregnant and puerperal women, lactating mothers.
8. Patients with a habit of tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence.
9. Self-reported immune-compromised states.
10. Already undergoing homoeopathic treatment for chronic disease within last 6 months.
11. Simultaneous participation in any other clinical trials 
 
Method of Generating Random Sequence   Permuted block randomization, variable 
Method of Concealment   Pre-numbered or coded identical Containers 
Blinding/Masking   Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded 
Primary Outcome  
Outcome  TimePoints 
0-10 numeric rating scale measuring intensity of
pain 
Baseline, month 1, month 2 
 
Secondary Outcome  
Outcome  TimePoints 
McGill Pain Questionnaire Short Form   Baseline, month 1, month 2 
Neck disability index   Baseline, month 1, month 2 
 
Target Sample Size   Total Sample Size="117"
Sample Size from India="117" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   03/04/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   None yet; to be published later 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [biswasswarup786@gmail.com].

  6. For how long will this data be available start date provided 01-01-2026 and end date provided 31-12-2031?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - Nil
Brief Summary   Cervical radiculopathy is a clinical condition resulting from compression of cervical nerve roots. The annual incidence is 107.3 per 100,000 for men and 63.5 per 100,000 for women. The incidence seems to peak in the fourth and fifth decades in life. Risk factors include lifting heaving objects, frequent diving from a board, driving equipment that vibrates, and trauma. Up to 30% of patients report the onset of pain in neck and arms when sitting, walking, or standing. Though the use of homoeopathic medicines is extensive globally to treat the condition, research evidence in favor of homeopathy is not well marked. So, we intend to undertake the trial to evaluate the efficacy and safety of homoeopathic medicines in the treatment of cervical radiculopathy. Though the use of homoeopathic medicines is prevalent globally to treat the condition, rigorous research evidence in support of homoeopathy in cervical radiculopathy has remained compromised. Under such circumstances, we intend to undertake this research project to evaluate the efficacy and safety of homeopathic medicines in the treatment of cervical radiculopathy in adults. A double-blind, randomized (2:1), placebo-controlled trial will be conducted on 117 adult participants with cervical radiculopathy at the outpatient department of D. N. De Homoeopathic Medical College and Hospital. Primary outcome measure is Numerical pain rating scale (NPRS), to be measured every month, up to 2 months. Secondary outcome measures are McGill Pain Questionnaire short-form (McGillPQ-SF) and Neck Disability Index (NDI), to be measured every month, up to 2 months. Comparative analysis will be carried out to detect group differences. 
Close